دورية أكاديمية

Adjuvant endocrine therapy for postmenopausal breast cancer in the era of aromatase inhibitors: an update.

التفاصيل البيبلوغرافية
العنوان: Adjuvant endocrine therapy for postmenopausal breast cancer in the era of aromatase inhibitors: an update.
المؤلفون: Mokbel, Ramia, Karat, Isabella, Mokbel, Kefah
المصدر: International Seminars in Surgical Oncology; 2006, Vol. 3, p31-4, 4p
مصطلحات موضوعية: BREAST cancer, CANCER patients, CYTOCHROME P-450, HORMONE therapy, PROGESTERONE receptors, STEROID hormones
مستخلص: There is overwhelming evidence that optimal adjuvant endocrine therapy for hormone sensitive breast cancer in postmenopausal women should include a third generation aromatase inhibitor (AI). On current evidence, adjuvant anstrozole or letrozole should be used upfront in such patients especially in those with high risk disease (node positive and/or tumours > 2 cm). The sequential approach of tamoxifen for 2–3 years followed by exemestane or anastrozole for 2–3 years is a reasonable alternative to 5 years of AI monotherapy in patients with low risk disease (node negative and tumour smaller than 2 cm) especially if the tumour is positive for estrogen and progesterone receptors. Node-positive patients completing 5 years of adjuvant tamoxifen should be offered letrozole for up 48 months. Further research is required to establish the long-term cardiovascular safety of AIs especially that of letrozole and exmestane, the optimal AI to use, duration of AI therapy and whether monotherapy with an AI for 5 years is superior to sequencing an AI after 2–3 years of tamoxifen. The bone mineral density (BMD) should be measured at baseline and monitored during therapy in women being treated with AIs. Anti-osteoporosis agents should such as bisphosphonates should be considered in patients at high risk of bone fractures. [ABSTRACT FROM AUTHOR]
Copyright of International Seminars in Surgical Oncology is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:14777800
DOI:10.1186/1477-7800-3-31